Sol-Gel Technologies Ltd.SLGLEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| M. Arkin Dermatology Ltd. | 60.52% | 18.1M | — | 2024-04-08 |
| The Phoenix Holdings Ltd. | 9.26% | 2.6M | — | 2024-02-12 |
| Phoenix Financial Ltd. | 8.87% | 2.5M | — | 2024-11-14 |
| Migdal Insurance & Financial Holdings Ltd | 5.31% | 1.2M | — | 2024-01-31 |
| Armistice Capital, LLC | 4.99% | 1.5M | ▼ -2.69pp | 2024-11-14 |
Insider Transactions
Net 90d: +$2.89M · buys $2.89M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-24 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 34.7K | $72.00 | $2.50M |
| 2026-03-24 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 5.0K | $72.00 | $360.0K |
| 2026-02-13 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 291 | $63.00 | $18.3K |
| 2026-02-02 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 100 | $58.00 | $5.8K |
| 2026-02-02 | Opaleye Management Inc. | 10% Owner | Buy (open market) | 100 | $58.00 | $5.8K |
1–5 of 5